Hisashi Hirano
Papers
1
Total Citations
11
H-Index
1
About
Dr. Hisashi Hirano is a leading urologic oncologist whose research centers on optimizing health-related quality of life (HRQOL) outcomes for men undergoing robot-assisted radical prostatectomy (RARP) for localized prostate cancer. His major contribution lies in the longitudinal assessment of patient-reported outcomes using the Expanded Prostate Cancer Index Composite (EPIC), providing critical insights into how nerve-sparing techniques influence post-surgical recovery and well-being. His most-cited work, a 2021 study examining HRQOL changes in Japanese men after RARP, has garnered 11 citations, establishing a foundation for culturally-specific, patient-centered care in urologic oncology. Dr. Hirano’s research bridges the gap between surgical precision and holistic patient experience, emphasizing the importance of functional preservation alongside oncologic control. By systematically evaluating the impact of surgical techniques on urinary, sexual, and bowel function, he has helped refine treatment protocols that prioritize long-term quality of life. His work is particularly notable for its focus on the Japanese population, addressing a significant gap in the literature and offering actionable data for clinicians worldwide. Dr. Hirano continues to shape the future of prostate cancer care, advocating for evidence-based approaches that empower patients through informed decision-making and improved survivorship outcomes.
Research Focus
Key Achievements
Top Papers
- 1